Immunome Inc.
IMNM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001472012
In the last 90 days, Immunome Inc. insiders filed 0 open-market purchases and 8 sales; 202 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Immunome Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- −2 vs. Q2 2022
- Shares held
- 2.39M
- −13.8K (−0.6%) vs. Q2 2022
- Total value
- $10.7M
- +$2.95M (+37.9%) vs. Q2 2022
- New holders
- 2
- 6 more added
- Sold out
- 4
- 2 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMNM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 202 | $2.50B |
| Q1 2026 | 202 | $2.54B |
| Q4 2025 | 183 | $2.54B |
| Q3 2025 | 153 | $1.07B |
| Q2 2025 | 142 | $738.7M |
| Q1 2025 | 143 | $518.4M |
| Q4 2024 | 121 | $566.3M |
| Q3 2024 | 115 | $754.7M |
| Q2 2024 | 114 | $578.4M |
| Q1 2024 | 103 | $903.6M |
| Q4 2023 | 57 | $229.9M |
| Q3 2023 | 35 | $19.7M |
| Q2 2023 | 35 | $15.4M |
| Q1 2023 | 30 | $9.34M |
| Q4 2022 | 28 | $4.85M |
| Q3 2022 | 24 | $10.7M |
| Q2 2022 | 26 | $7.78M |
| Q1 2022 | 29 | $15.4M |
| Q4 2021 | 30 | $36.4M |
| Q3 2021 | 35 | $58.3M |
| Q2 2021 | 29 | $41.1M |
| Q1 2021 | 31 | $64.7M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Immunome Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BNP Paribas Arbitrage, SA | 67 | $297 | 0.00% | +67 | New |
| Newbridge Financial Services Group, Inc. | 375 | $2.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,229 | $5.00K | 0.00% | +1,229 | New |
| Wells Fargo & Company | 1,851 | $8.00K | 0.00% | −1−0.1% | Reduced |
| Group One Trading, L.P. | 2,276 | $10.0K | 0.00% | +2,228+4,641.7% | Added |
| Simplex Trading, LLC | 3,642 | $16.0K | 0.00% | +1,679+85.5% | Added |
| Wealth Architects, LLC | 11,110 | $49.0K | 0.01% | 00.0% | Unchanged |
| Morgan Stanley | 12,134 | $53.0K | 0.00% | −796−6.2% | Reduced |
| UBS Group AG | 15,271 | $68.0K | 0.00% | +13,943+1,049.9% | Added |
| Northern Trust Corp | 16,798 | $75.0K | 0.00% | 00.0% | Unchanged |
| Neuberger Berman Group LLC | 19,444 | $86.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 21,500 | $95.0K | 0.00% | 00.0% | Unchanged |
| Sterling Investment Advisors, Ltd. | 21,627 | $96.0K | 0.04% | 00.0% | Unchanged |
| Baldwin Investment Management, LLC | 25,394 | $113.0K | 0.04% | 00.0% | Unchanged |
| Magnus Financial Group LLC | 25,759 | $114.0K | 0.02% | 00.0% | Unchanged |
| Royal Bank of Canada | 28,495 | $126.0K | 0.00% | +116+0.4% | Added |
| State Street Corp | 29,591 | $131.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 41,452 | $183.0K | 0.00% | +2,241+5.7% | Added |
| Cerity Partners LLC | 56,962 | $253.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 81,406 | $361.0K | 0.00% | 00.0% | Unchanged |
| Bank of Montreal | 92,593 | $529.0K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 373,685 | $1.66M | 0.00% | +3,149+0.8% | Added |
| Alpine Global Management, LLC | 718,235 | $3.19M | 0.75% | 00.0% | Unchanged |
| Prentice Capital Management, LP | 791,821 | $3.52M | 2.61% | 00.0% | Unchanged |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −13,159−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −12,052−100.0% | Sold out |
| Titleist Asset Management, Ltd. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −2,489−100.0% | Sold out |